CA2615558A1 - Caveoline-3 et culture in vitro du virus de l'hepatite c - Google Patents

Caveoline-3 et culture in vitro du virus de l'hepatite c Download PDF

Info

Publication number
CA2615558A1
CA2615558A1 CA002615558A CA2615558A CA2615558A1 CA 2615558 A1 CA2615558 A1 CA 2615558A1 CA 002615558 A CA002615558 A CA 002615558A CA 2615558 A CA2615558 A CA 2615558A CA 2615558 A1 CA2615558 A1 CA 2615558A1
Authority
CA
Canada
Prior art keywords
caveolin
cell
hcv
hepatitis
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002615558A
Other languages
English (en)
Inventor
Marcello Merola
Stefania Crotta
Alessia Bianchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2615558A1 publication Critical patent/CA2615558A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
CA002615558A 2005-07-18 2006-07-18 Caveoline-3 et culture in vitro du virus de l'hepatite c Abandoned CA2615558A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70046205P 2005-07-18 2005-07-18
US60/700,462 2005-07-18
PCT/IB2006/002565 WO2007010398A2 (fr) 2005-07-18 2006-07-18 Caveoline-3 et culture in vitro du virus de l'hepatite c

Publications (1)

Publication Number Publication Date
CA2615558A1 true CA2615558A1 (fr) 2007-01-25

Family

ID=37547530

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002615558A Abandoned CA2615558A1 (fr) 2005-07-18 2006-07-18 Caveoline-3 et culture in vitro du virus de l'hepatite c

Country Status (4)

Country Link
EP (1) EP1910522A2 (fr)
JP (1) JP2009513109A (fr)
CA (1) CA2615558A1 (fr)
WO (1) WO2007010398A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100984735B1 (ko) * 2009-05-28 2010-10-01 동국대학교 산학협력단 신개념 신약개발을 위한 타겟 단백질­단백질 상호작용을 저해하는 신약후보물질의 스크리닝 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004044182A2 (fr) * 2002-11-13 2004-05-27 Washington University Lignees cellulaires hautement permissives pour replication de l'arn du virus de l'hepatite c
WO2006038129A2 (fr) * 2004-10-01 2006-04-13 Novartis Vaccines And Diagnostics Srl Systeme de replication du virus de l'hepatite c

Also Published As

Publication number Publication date
WO2007010398A2 (fr) 2007-01-25
EP1910522A2 (fr) 2008-04-16
JP2009513109A (ja) 2009-04-02
WO2007010398A3 (fr) 2007-04-19

Similar Documents

Publication Publication Date Title
US7674612B2 (en) Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof
WO2014122660A1 (fr) Inhibiteurs de cd14 en tant que traitement efficace pour l'infection par vhc
US20100159467A1 (en) Method for replicating the hepatitis c virus
EP1694694A2 (fr) Virus de l'hepatite c capable de replication et procedes d'utilisation
AU2012278960B2 (en) HCV genotype 3 replicons
JP2012504647A (ja) 新規なｈｃｖ侵入因子、オクルディン
EP3027740B1 (fr) Systèmes de culture de cellules infectieuses de génotype 2b pleine longueur du vhc de titre élevé et leurs applications
AU2012278959B2 (en) HCV genotype 4 replicons
EP3212775B1 (fr) Systèmes optimisés de culture de cellules pleine longueur infectées par le vhc et leurs applications
CA2615558A1 (fr) Caveoline-3 et culture in vitro du virus de l'hepatite c
JP5371756B2 (ja) Ｃ型肝炎ウイルスの産生のための組織培養系
Walter et al. Ion channel function and cross-species Determinants in viral assembly of nonprimate hepacivirus p7
WO2013138670A1 (fr) Mutants ns5 du virus de la fièvre jaune en tant que candidats vaccinaux contre le flavivirus
Cao et al. Scavenger receptor class B type I is more conducive for genotype 1b hepatitis C virus internalization than low-density lipoprotein receptor.
Delivogiatzi The effects of HCV Core protein on nuclear pore proteins and nucleocytoplasmic transport
Kohlway Cause and effect: Hepatitis C virus infection and host innate immune response
Aligo Defining the role of the nonstructural protein 4B C-terminal domain in Hepatitis C Virus replication
Domingues Control of hepatitis C virus genome replication by viral factors and mediators of host intrinsic immunity
Magri Exploration of new uracil-based compounds as novel inhibitors of Hepatitis C Virus replication
King Characterisation of the membrane and protein interactions of the Hepatitis C Virus NS2
Dhillon Investigating virus entry using cell-culture adapted hepatitis C virus
Delcorde Investigating Host-Viral Interactions in Liver Lipid Homeostasis and HCV Pathology
NZ619298B2 (en) Hcv genotype 3 replicons
Bouter The Role of NS3 Helicase Domain in Hepatitis C Virus Particle Assembly
NZ619294B2 (en) Hcv genotype 4 replicons

Legal Events

Date Code Title Description
FZDE Discontinued